The global Personalized Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics.The personalized cell therapy is mainly developed for the treatment of high unmet need disease
This report aims to provide a comprehensive presentation of the global market for Personalized Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cell Therapy. This report contains market size and forecasts of Personalized Cell Therapy in global, including the following market information:
Global Personalized Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Cell Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Personalized Cell Therapy include Novartis AG, Vericel Corporation, Bellicum Pharmaceuticals, MolMed SpA, Cytori Therapeutics Inc, Gilead Sciences, Inc, Celgene Corporation, Bluebird Bio and Aurora Biopharma Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Personalized Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Global Personalized Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cell Therapy Market Segment Percentages, by Type, 2022 (%)
- By Cell Type
- Hematopoietic Stem Cell
- Skeletal Muscle Stem Cell
- Mesenchymal Stem Cells
- Lymphocytes
- Others
- By Technique
- Platelet Transfusions
- Bone Marrow Transplantation
- Packed Red Cell Transfusions
- Organ Transplantation
Global Personalized Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cell Therapy Market Segment Percentages, by Application, 2022 (%)
- Cardiovascular Diseases
- Neurological Disorders
- Inflammatory Diseases
- Diabetes
- Cancer
- Others
Global Personalized Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalized Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Personalized Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Personalized Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Vericel Corporation
- Bellicum Pharmaceuticals
- MolMed SpA
- Cytori Therapeutics Inc
- Gilead Sciences, Inc
- Celgene Corporation
- Bluebird Bio
- Aurora Biopharma Inc
- Saneron CCEL TherapeuticsInc
- Kuur Therapeutics
- MediGene AG
- Sangamo Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalized Cell Therapy, market overview.
Chapter 2: Global Personalized Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Personalized Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
